SE0000675D0 - Monoclonal antibodies - Google Patents

Monoclonal antibodies

Info

Publication number
SE0000675D0
SE0000675D0 SE0000675A SE0000675A SE0000675D0 SE 0000675 D0 SE0000675 D0 SE 0000675D0 SE 0000675 A SE0000675 A SE 0000675A SE 0000675 A SE0000675 A SE 0000675A SE 0000675 D0 SE0000675 D0 SE 0000675D0
Authority
SE
Sweden
Prior art keywords
antibodies
gla
peptides
methods
proteins
Prior art date
Application number
SE0000675A
Other languages
English (en)
Inventor
Johan Stenflo
Leisa Mary Stenberg
Mark Alan Brown
Original Assignee
Protease Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protease Ab filed Critical Protease Ab
Priority to SE0000675A priority Critical patent/SE0000675D0/sv
Publication of SE0000675D0 publication Critical patent/SE0000675D0/sv
Priority to PCT/SE2001/000430 priority patent/WO2001064748A1/en
Priority to CA002399847A priority patent/CA2399847A1/en
Priority to EP01908573A priority patent/EP1261642A1/en
Priority to JP2001564241A priority patent/JP2003530089A/ja
Priority to AU2001236315A priority patent/AU2001236315A1/en
Priority to US10/220,548 priority patent/US7439025B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
SE0000675A 2000-03-02 2000-03-02 Monoclonal antibodies SE0000675D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0000675A SE0000675D0 (sv) 2000-03-02 2000-03-02 Monoclonal antibodies
PCT/SE2001/000430 WO2001064748A1 (en) 2000-03-02 2001-03-01 Antibodies binding a gamma carboxyglutamic acid displaying epitope
CA002399847A CA2399847A1 (en) 2000-03-02 2001-03-01 Antibodies binding a gamma carboxyglutamic acid displaying epitope
EP01908573A EP1261642A1 (en) 2000-03-02 2001-03-01 Antibodies binding a gamma carboxyglutamic acid displaying epitope
JP2001564241A JP2003530089A (ja) 2000-03-02 2001-03-01 γ―カルボキシグルタミン酸を提示するエピトープを結合する抗体
AU2001236315A AU2001236315A1 (en) 2000-03-02 2001-03-01 Antibodies binding a gamma carboxyglutamic acid displaying epitope
US10/220,548 US7439025B2 (en) 2000-03-02 2001-03-01 Antibodies binding a gamma carboxyglutamic acid displaying epitope

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000675A SE0000675D0 (sv) 2000-03-02 2000-03-02 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
SE0000675D0 true SE0000675D0 (sv) 2000-03-02

Family

ID=20278646

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000675A SE0000675D0 (sv) 2000-03-02 2000-03-02 Monoclonal antibodies

Country Status (7)

Country Link
US (1) US7439025B2 (sv)
EP (1) EP1261642A1 (sv)
JP (1) JP2003530089A (sv)
AU (1) AU2001236315A1 (sv)
CA (1) CA2399847A1 (sv)
SE (1) SE0000675D0 (sv)
WO (1) WO2001064748A1 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110468213A (zh) * 2019-07-31 2019-11-19 扬州大学 一种金茅黑鸡肌苷酸和肌内脂肪含量相关的分子标记与应用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000675D0 (sv) * 2000-03-02 2000-03-02 Protease Ab Monoclonal antibodies
US7590997B2 (en) * 2004-07-30 2009-09-15 Broadband Itv, Inc. System and method for managing, converting and displaying video content on a video-on-demand platform, including ads used for drill-down navigation and consumer-generated classified ads
US9344765B2 (en) * 2004-07-30 2016-05-17 Broadband Itv, Inc. Dynamic adjustment of electronic program guide displays based on viewer preferences for minimizing navigation in VOD program selection
US7631336B2 (en) * 2004-07-30 2009-12-08 Broadband Itv, Inc. Method for converting, navigating and displaying video content uploaded from the internet to a digital TV video-on-demand platform
US20110030013A1 (en) * 2004-07-30 2011-02-03 Diaz Perez Milton Converting, navigating and displaying video content uploaded from the internet to a digital TV video-on-demand platform
US9584868B2 (en) * 2004-07-30 2017-02-28 Broadband Itv, Inc. Dynamic adjustment of electronic program guide displays based on viewer preferences for minimizing navigation in VOD program selection
CA2592054A1 (en) * 2004-12-23 2006-06-29 Novo Nordisk Health Care Ag Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
US20080206276A1 (en) 2005-07-08 2008-08-28 Michael Otto Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
US20100190697A1 (en) * 2006-09-13 2010-07-29 The Trustees Of Columbia University In The City If Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
US20110212448A1 (en) * 2008-08-27 2011-09-01 Dina Cristina Fernandes Rodrigues Da Costa Simes Gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof
FR2948664B1 (fr) * 2009-07-31 2013-11-01 Lfb Biotechnologies Procede pour la purification de proteines de la coagulation a domaine gla
FR2948665B1 (fr) * 2009-07-31 2011-09-23 Lfb Biotechnologies Procede pour la purification de proteines de la coagulation a domaine gla actives
RU2012133474A (ru) 2010-01-18 2014-02-27 Ново Нордиск Хелс Кеа Аг Очистка факторов свертывания крови
JP5725462B2 (ja) * 2013-07-26 2015-05-27 国立大学法人広島大学 アスベスト結合タンパク質の利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
JPH0739439B2 (ja) * 1989-03-16 1995-05-01 寳酒造株式会社 モノクローナル抗体及びその使用方法
AU2861092A (en) 1992-10-08 1994-05-09 Loma Linda University Medical Center Antibody to naturally-occurring aminomalonic acid and uses therefor
JPH0720127A (ja) 1993-05-07 1995-01-24 Eisai Co Ltd 各種ｐｉｖｋａの測定方法および測定試薬
DE4333053A1 (de) * 1993-09-29 1995-03-30 Opel Adam Ag Brennkraftmaschine mit einem Luftansaugsystem
US6379975B1 (en) * 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
FI973371A0 (fi) 1997-08-15 1997-08-15 Jukka Hellman Nya isolerade peptider
ATE217889T1 (de) * 1998-08-28 2002-06-15 Genentech Inc Humane antikörper gegen faktor ix/ixa
SE0000675D0 (sv) * 2000-03-02 2000-03-02 Protease Ab Monoclonal antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110468213A (zh) * 2019-07-31 2019-11-19 扬州大学 一种金茅黑鸡肌苷酸和肌内脂肪含量相关的分子标记与应用

Also Published As

Publication number Publication date
AU2001236315A1 (en) 2001-09-12
WO2001064748A1 (en) 2001-09-07
JP2003530089A (ja) 2003-10-14
US20030138844A1 (en) 2003-07-24
CA2399847A1 (en) 2001-09-07
US7439025B2 (en) 2008-10-21
EP1261642A1 (en) 2002-12-04

Similar Documents

Publication Publication Date Title
SE0000675D0 (sv) Monoclonal antibodies
BR9914373A (pt) Ensaio para conformação relacionada à doença de uma proteìna.
BR0009206A (pt) Isolamento e análise de proteina
AR038568A1 (es) Anticuerpos anti-a beta y su uso
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
GT200800132A (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
AT500379B8 (de) Tau-proteine
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
EP1708745A4 (en) ANTIBODIES FOR ONCOGEN STRAINS OF HPV AND METHODS OF USE
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
IL145689A0 (en) Methods
ATE392620T1 (de) Nachweismittel von patologischen veränderungen des proteins app und ihre verwendungen
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
EA200200974A1 (ru) Моноклональные антитела к рецептору лпнп человека, их получение и применение
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
WO2005102938A3 (en) Antibodies specific for bcr-abl fusion protein and uses thereof
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
EP1265073A3 (en) Methods for determining plasma free drug concentration